Search Within

Shanu Modi

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (14)
  2. Meeting Abstract (8)
  3. Review (1)
Groups
  1. Breast Medicine Service (23)
  2. Department of Medicine (23)
  3. Sloan Kettering Institute Postdocs (23)
  4. Solid Tumor Oncology Division (23)
  5. GSK Faculty (22)
  6. Sloan Kettering Institute Faculty (16)

More Groups

People
  1. Gabriela Chiosis (14)
  2. Tony Taldone (12)
  3. Komal Jhaveri (10)
  4. Anna Rodina Balingcongan (9)
  5. Mark Dunphy (9)
  6. Jason Lewis (8)

More People

Years
  1. 2024 (2)
  2. 2023 (1)
  3. 2022 (2)
  4. 2020 (5)
  5. 2019 (4)
  6. 2018 (1)

More Years

Publications
  1. Cancer Research (6)
  2. Cancer Cell (2)
  3. Journal of Clinical Oncology (2)
  4. Nature Communications (2)
  5. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (1)
  6. Cell Reports (1)

More Publications

Publishers
  1. American Association for Cancer Research (7)
  2. American Society of Clinical Oncology (3)
  3. Cell Press (3)
  4. Nature Publishing Group (3)
  5. American Society for Biochemistry and Molecular Biology (1)
  6. Edizioni Minerva Medica (1)

More Publishers

Results (23)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Paradigms for precision medicine in epichaperome cancer therapy
    Journal Article

    Pillarsetty, N.; Jhaveri, K.; Taldone, T.; Caldas-Lopes, E.; Punzalan, B.; Joshi, S.; Bolaender, A.; Uddin, M. M.; Rodina, A.; Yan, P.; more...
    Cancer Cell (2019)

    Fulltext@MSK | Save
  • Copper-64 trastuzumab PET imaging: A reproducibility study
    Journal Article

    Carrasquillo, J. A.; Morris, P. G.; Humm, J. L.; Smith-Jones, P. M.; Beylergil, V.; Akhurst, T.; O'Donoghue, J. A.; Ruan, S.; Modi, S.; Hudis, C. A.; more...
    Quarterly Journal of Nuclear Medicine and Molecular Imaging (2019)

    Fulltext@MSK | Save
  • Tumor epichaperome expression using (124)I PU-H71 PET (PU-PET) as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2 negative (HER2-) metastatic breast cancer (MBC)
    Meeting Abstract

    Jhaveri, K.; Dunphy, M.; Wang, R.; Comen, E.; Fornier, M.; Moynahan, M. E.; Bromberg, J.; Ma, W.; Patil, S.; Taldone, T.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Chaperome heterogeneity and its implications for cancer study and treatment
    Review

    Wang, T.; Rodina, A.; Dunphy, M. P.; Corben, A.; Modi, S.; Guzman, M. L.; Gewirth, D. T.; Chiosis, G.
    Journal of Biological Chemistry (2019)

    Fulltext@MSK | Save
  • The genomic landscape of endocrine-resistant advanced breast cancers
    Journal Article

    Razavi, P.; Chang, M. T.; Xu, G.; Bandlamudi, C.; Ross, D. S.; Vasan, N.; Cai, Y.; Bielski, C. M.; Donoghue, M. T. A.; Jonsson, P.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Phase 1 study of the antibody-drug conjugate (ADC) SGN-LIV1A in patients with heavily pretreated metastatic breast cancer
    Meeting Abstract

    Forero-Torres, A.; Modi, S.; Specht, J.; Miller, K.; Weise, A.; Burris, H.; Liu, M.; Krop, I.; Pusztai, L.; Kostic, A.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • The epichaperome is an integrated chaperome network that facilitates tumour survival
    Journal Article

    Rodina, A.; Wang, T.; Yan, P.; Gomes, E. D.; Dunphy, M. P. S.; Pillarsetty, N.; Koren, J. 3rd; Gerecitano, J. F.; Taldone, T.; Zong, H.; more...
    Nature (2016)

    Fulltext@MSK | Save
  • Neratinib for ERBB2 mutant, HER2 non-amplified, metastatic breast cancer: Preliminary analysis from a multicenter, open-label, multi-histology phase II basket trial
    Meeting Abstract

    Hyman, D. M.; Piha-Paul, S. A.; RodoĢn, J.; Saura, C.; Puzanov, I.; Shapiro, G. I.; Loi, S.; Joensuu, H.; Hanrahan, A. J.; Modi, S.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Development of a noninvasive assay to determine drug concentration in tumor during hsp90 inhibitor therapy
    Meeting Abstract

    Taldone, T.; Pillarsetty, N.; Dunphy, M. P. S.; Gerecitano, J. F.; Caldas-Lopes, E.; Beattie, B.; Peter, R. I.; Kang, Y. L.; Rodina, A.; Yan, P.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Phase I trial of the HSP-90 inhibitor PU-H71
    Meeting Abstract

    Gerecitano, J. F.; Modi, S.; Rampal, R.; Drilon, A. E.; Fury, M. G.; Gounder, M. M.; Harding, J. J.; Hyman, D. M.; Varghese, A. M.; Voss, M. H.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save